Introduction
AmpC β-lactamases are cephalosporinases that may be either chromosomal or plasmid-encoded in Gram-negative organisms. Plasmidencoded ampC genes are considered to have originated from the inducible, chromosomal ampC of organisms such as Enterobacter spp., Citrobacter freundii, Morganella morganii, Hafnia alvei and Aeromonas spp. 1 More than 50 different ampC genes have been reported in clinical isolates worldwide including over 20 plasmid-borne ampC genes. Organisms producing AmpC β-lactamases can be resistant to all β-lactam antibiotics except cefepime, cefpirome and carbapenems. 2, 3 ampR encodes for a transcriptional regulator of ampC. It is located upstream of ampC and is divergently transcribed. In the presence of certain cofactors, AmpR can act as a repressor of ampC expression or as an activator upon addition of certain β-lactams or other stimuli. 4 Plasmid-encoded ampC genes may or may not be associated with ampR. For example, only bla ACT-1 , 5 bla DHA-1 , 6 and bla have been shown to be associated with ampR.
Salmonella spp. are one of the most virulent members of the Enterobacteriaceae family. 8, 9 Virulence of a pathogen can be enhanced by either gain of function due to acquisition of virulence genes or loss of function due to deletion of chromosomal genes. 10, 11 Enhanced virulence of Shigella flexneri and Shigella dysenteriae has been found to be associated with an approximately 190 kb deletion (a 'black hole') in the chromosome. 10 In both S. dysenteriae and S. flexneri, the 'black hole' included the ampC β-lactamase gene. 10 Acquisition of drug resistance by a pathogen can lead to fitness loss such as reduced growth and virulence. 12, 13 Salmonella spp. do not encode chromosomal ampC genes. 14, 15 Therefore, the question becomes whether acquisition of ampC by Salmonella leads to biolog- ampC expression and biological cost in Salmonella ical cost such as reduced growth rate or virulence. Morosini et al. 16 addressed this question by mobilizing plasmids which contained the cloned chromosomal ampC and ampR together or the ampC alone from Enterobacter cloacae into Salmonella typhimurium. They reported that acquisition of a plasmid expressing ampC alone by Salmonella was associated with a biological cost indicated by reduced growth rate in laboratory medium and reduced capacity to invade mammalian cells. Furthermore, the authors reported that simultaneous acquisition of ampC-ampR was a requirement for keeping ampC expression at low constitutive levels, which allowed Salmonella to overcome the deleterious effect of high-level ampC expression.
Our laboratory recently described S. typhimurium strain 100, isolated from a patient with gastroenteritis that produced three different β-lactamases, OXA-30, SHV-9 and CMY-7. 17 CMY-7 belongs to a family of plasmid-encoded AmpC enzymes and is 93% similar to the chromosomally encoded AmpC β-lactamase of C. freundii. In this study, we investigated the influence of bla CMY-7 expression on growth and virulence of S. typhimurium strain 100.
Materials and methods

Bacterial strains and plasmids
S. typhimurium strain 100 has been previously described. 17 C. freundii 21 is a clinical isolate which has an inducible chromosomal ampC, whereas C. freundii 21 M is a derepressed (clinically non-inducible) mutant derived from C. freundii 21. 18 S. typhimurium strain LT2 was a gift from Dr Diana Jones (University of Wisconsin-Madison). Sodium azide-resistant Escherichia coli J53Az R was kindly supplied by Dr George Jacoby (Lahey Clinic, Burlington, MA, USA). pCMY-7 designates the plasmid within S. typhimurium 100 which encodes bla . pAH1 designates the plasmid encoding the bla CMY-7 structural gene and 496 bp of the upstream region cloned into a high-copy number (>100 copies per cell) cloning vector, pCR-TOPO-XL, a pUC 19 derived vector (Invitrogen, Carlsbad, CA, USA). 19 S. typhimurium LT2:pCMY-7 is the Salmonella transconjugant harbouring pCMY-7 and LT2:pAH1 designates the Salmonella LT2 transformant harbouring pAH1.
Polymerase chain reaction (PCR) and DNA sequencing
DNA template was prepared from S. typhimurium strains and PCR was carried out as previously described. 17 Primers used in this study are listed in Table 1 . PCR products were sequenced directly after treating with ExoSap (USB, Columbus, OH, USA) to remove unwanted nucleotides and primers. PCR amplicons used as sequence templates were generated at least twice, on separate occasions. Sequencing was carried out by automated PCR cycle-sequencing with dye-terminator chemistry using a DNA stretch sequencer from Applied Biosystems (Foster City, CA, USA). Sequence analyses were carried out online using the BLAST program (www.ncbi.nlm.nih.gov).
Plasmid analysis and plasmid copy number determination
Plasmid profiles were determined as previously described. 17 The relative copy number of pCMY-7 was determined by a PCR-based methodology using primers CMY71F and CMY71R (Table 1) as previously described. 20 Primers SalAmpDF1 and SalAmpDR1 (Table 1) were used for amplification of ampD of S. typhimurium strain 100, which was used as a single copy gene reference for copy number determination. Genome Walker (Clontech, Palo Alto, CA, USA), a PCR-based methodology that permits amplification of unknown DNA sequence adjacent to known sequence was used to amplify the upstream region of the gene.
Upstream sequence determination of bla
Gene specific primers CMY7GSP1 and CMY7GSP2 (Table 1) were used in addition to adapters supplied by the manufacturer to generate a Genome Walker library. An upstream fragment of 524 bp was generated and sequenced with primers CMYUPF1 and CMYGSP1.
Primer extension analysis
RNA was isolated using Trizol-Max (Invitrogen). Primers (CMYPE and CMY2PE for bla CMY-7 and chromosomal ampC of C. freundii, respectively, Table 1 ) were annealed to 20 µg of total RNA at 50°C and primer extension was carried out using 100 U of MuLV reverse transcriptase (Perkin-Elmer, Norwalk, CT, USA) as previously described. 5 One microgram of RNA was used for 16S rRNA reactions with primer B. Extension products were visualized by exposing the gel to a storage 
Conjugation experiments
Conjugation experiments were carried out by a liquid mating procedure. 21 Initially, S. typhimurium 100 plasmids were transferred to the sodium azide-resistant E. coli, J53Az R , with Luria-Bertani (LB) agar containing 150 mg/L sodium azide (Sigma, St Louis, MO, USA) and 50 mg/L ampicillin (Sigma) as the selection medium. The plasmid containing bla CMY-7 was then conjugated from the azide-resistant E. coli J53Az R to S. typhimurium strain LT2 and the transconjugant was designated LT2:pCMY-7. Chromagar Salmonella (Chromagar, Paris, France) was used to differentiate between E. coli (blue) and Salmonella (pink) colonies. The transconjugants were screened for the presence of bla by PCR using primers CMY25F1 and CMY2DR1 (Table 1) as described above following each mobilization step.
Cloning of bla CMY-7 and the upstream region
The bla CMY-7 and 493 bp upstream region was amplified by PCR as described above using primers CMYUPF1 and CMY2DR1 (Table 1 ).
The PCR product was purified using a SNAP column, ligated into pCR-TOPO-XL cloning vector and transformed into E. coli Top10 competent cells (Invitrogen). The resulting plasmid (pAH1) was isolated and the sequence of the PCR-generated insert was verified using primers CMYUPF1, CMY25F1, CMY7GSP2 and CMY2DR1 (Table 1 .) Transformation was carried out by electroporation using a Bio-Rad gene pulser (set at 2.5 kV, 25 µF and 400 ohms) and S. typhimurium LT2 as the recipient. Transformants were selected by plating on LB agar plates containing 50 mg/L ampicillin (Sigma).
Growth curves
Overnight cultures of S. typhimurium strains were grown in 5 mL of LB (Difco, Sparks, MD, USA) medium and 1 mL was used to inoculate 100 mL of LB medium. The cultures were grown with good aeration in an orbital shaker (140 rpm) at 37°C for 10 h. During this time, aliquots of culture were removed hourly for measurement of cell density (i.e. the OD 600 ) and determination of viable counts.
Antibiotic susceptibility testing
Cefoxitin MICs for S. typhimurium strains 100, LT2, LT2:pCMY-7 and LT2:pAH1 were determined by Etest according to the National Committee for Clinical Laboratory Standards (NCCLS) protocol. 22
Disc induction assay
Disc induction assays were carried out as previously described 23 using cefoxitin (30 µg) and cefotaxime (30 µg) placed 13 mm apart on MuellerHinton agar plates.
Invasion assay
In vitro invasion assays using mammalian gastric carcinoma tissue culture cells (ATCC CRL/1739) were carried out with a multiplicity of infection (MOI) of 20 as previously described. 24 The invaded bacteria were released by lysing the mammalian cells with 1×PBS-0.1% Triton X-100, and the number of intracellular bacteria (cfu) was determined by plating on LB agar plates containing 50 mg/L ampicillin (Sigma).
Nucleotide accession number
The GenBank accession number for bla CMY-7 and associated upstream sequences is AY324388.
Results
Search for ampR
A disc induction assay was used to phenotypically determine whether bla CMY-7 was inducible. No induction was observed using this technique which suggested the absence of a functional AmpR. To confirm the absence of ampR, an upstream region of 524 base pairs was generated and sequenced ( Figure 1 ). No ampR sequence was found. However, analysis of DNA sequences showed that 32 of the 38 bases 
Special features of CMY-7 upstream sequences
Analysis of upstream sequences of bla CMY-7 revealed a partial sequence of an insertion element, ISEcp1 (nucleotides 291-407; Figure 1 ). The start site of transcription for bla CMY-7 expression was mapped to nucleotide 341 (183 nucleotides upstream from the initiation codon), within the ISEcp1 sequence. This location suggested that bla CMY-7 expression was driven by putative -35 and -10 promoter elements located within this IS element (Figures 1 and 2) . Interestingly, the -10 (TACAAT) and -35 (TTGAAA) elements located within ISEcp1 had more similarity (83%, 10/12 bases) to consensus E. coli -10 (TATAAT) and -35 (TTGACA) elements than the chromosomal C. freundii ampC promoter elements (58%, 7/12 bases) -10 (CACACT) and -35 (TTGTCA) (Figure 1 ). Sequences further upstream of ISEcp1 (nucleotides 33-290) showed similarity to the traA gene sequence of IncI1 plasmid R64. 25 Expression of bla Plasmid profile and relative copy number analysis revealed that pCMY-7 was present in two copies in S. typhimurium strain 100 (data not shown). The ampD of S. typhimurium strain 100 was used as a single copy gene reference for gene copy determination of bla . bla CMY-7 is considered to have originated from the chromosomal ampC of C. freundii and a derepressed mutant is considered to produce high levels of AmpC conferring clinical resistance. 3, 18 Therefore, the level of bla CMY-7 expression in S. typhimurium strain 100 was compared with the expression of the chromosomal ampC of C. freundii strain 21 and C. freundii 21 M, a derepressed mutant, by primer extension analysis. The expression of the bla CMY-7 transcript in S. typhimurium strain 100 was ∼965-fold higher than C. freundii strain 21 and ∼4.1-fold higher than C. freundii 21 M. The expression data were normalized using 16S rRNA from the same RNA preparations.
Effect of AmpC expression on growth and virulence
An AmpC β-lactamase has been implicated to decrease growth and virulence in an S. typhimurium isolate which expressed the enzyme at high levels. 16 To test this hypothesis, a Salmonella transconjugant (LT2:pCMY-7) which expressed bla CMY-7 from pCMY-7 and a transformant (LT2:pAH1) expressing a cloned bla CMY-7 were evaluated. The cefoxitin MIC values for the clinical isolate S. typhimurium 100, and strains LT2:pCMY-7 and LT2:pAH1 were ≥256 mg/L. The cefoxitin MIC was 2 mg/L for the recipient strain, LT2. The growth of S. typhimurium 100 was comparable to S. typhimurium LT2 and LT2:pCMY-7 as determined by optical density at 600 nm and viable counts (Figure 3a and b) . At 10 h post-inoculation, a 6-7 log increase in cfu/mL was noted for all three strains. However, the growth of LT:pAH1 was dramatically reduced (cfu/mL ∼10 6 ) compared to the other three Salmonella strains (cfu/mL ∼10 10 ) (Figure 3b ). The effect of high-level bla CMY-7 expression on the ability of Salmonella strains to invade mammalian cells was studied using gastric carcinoma cells. Approximately 8.3% of the S. typhimurium strain The bla CMY-7 transcript and C. freundii chromosomal ampC transcripts were mapped using 20 µg of total RNA and primers CMYPE and CMY2PE, respectively. The 16S rRNA-specific extension product was obtained using 1 µg of total RNA and primer B (Table 1) . C. freundii chromosomal ampC specific extended product of both wild-type (C. freundii 21) and derepressed mutant isolate (C. freundii 21 M), bla CMY-7 and 16S rRNA are indicated by the arrows. The sequencing ladder was generated from the bla CMY-2 sequence. (b) Bar graph representing bla CMY-7 expression relative to C. freundii chromosomal ampC expression. Each value represents the mean of two experiments. Error bars represent the standard deviations.
at Pennsylvania State University on February 21, 2013 http://jac.oxfordjournals.org/ Downloaded from 100 inoculum invaded the mammalian cells as revealed by in vitro invasion assays. Figure 4 demonstrates the invasion potential of the S. typhimurium strains LT2, LT2:pCMY-7 and LT2:pAH1 compared to the invasion potential of S. typhimurium strain 100 which was set at 100%. In comparison to S. typhimurium strain 100, the invasion potentials of LT2:pCMY-7, LT2:pAH1 and LT2 and were 31.3%, 6.7% and 11.2%, respectively (Figure 4 ).
Discussion
The acquisition of antibiotic resistance in bacteria has been associated with certain types of biological costs for the organism. However, compensatory mutations within the organism can ameliorate biological cost without the loss of antibiotic resistance. 12, 26, 27 The biological consequences of high-level ampC expression in S. typhimurium has been examined by Morosini et al. 16 using a laboratory constructed model. Those data correlated reduced growth and a decreased capacity to invade mammalian cells with high-level ampC expression. The work presented here sought to take these observations one step further and examine the biological cost associated with a clinical isolate of S. typhimurium expressing a plasmid-encoded AmpC β-lactamase, CMY-7. The data presented in this paper show that high-level expression of a plasmid-encoded ampC β-lactamase gene did not compromise the virulent phenotype of a clinical S. typhimurium strain. Biological cost of high-level ampC expression was observed for the transformant as demonstrated by the differences observed in the growth and invasion potential of the transconjugant compared to the transformant expressing bla . Therefore, the biological cost of high-level AmpC production is compensated by plasmid-encoded factors and not controlled by repressing ampC expression. The model system examining biological cost of ampC expression suggested that isolates of S. typhimurium required the co-acquisition of ampR leading to AmpR production thus keeping ampC expression at low levels. 16 At the time of development of the Morosini model, only the inducible plasmid-encoded ampC gene, bla DHA-1 , had been found in Salmonella. 6 Therefore one of the objectives of this study was to determine how bla CMY-7 was regulated. In the clinical isolate, S. typhimurium strain 100, induction could not be demonstrated and sequence analysis showed no ampR associated with bla CMY-7 . However, only part of the AmpR binding site was present. Some plasmidencoded ampC genes, such as bla CMY-2 (bla BIL-1 ) 3 and bla MIR-1 also have partial AmpR binding sites indicating putative chromosomal origins of these genes. 28, 29 Primer extension demonstrated that the level of bla CMY-7 expression was ∼965-fold and ∼4.1-fold higher than a wild-type and a derepressed mutant of C. freundii strain 21 M, respectively. The level of transcription and the level of RNA expressed by S. typhimurium strain 100 was very surprising given that the bla CMY-7 gene was derived from the chromosomal ampC of C. freundii. In addition, primer extension data mapped the start site of transcription for bla CMY-7 135 nucleotides upstream from the C. freundii wild-type and derepressed mutant start sites. The absence of ampR in E. coli transformants indicates that expression of ampC increases 2.5-to 8.5-fold. 30, 31 Therefore, the 965-fold increase in ampC RNA expression observed in this study for bla CMY-7 is clearly the result of more than just the deletion of ampR.
Sequence analysis revealed interesting aspects of the upstream region of bla . A partial sequence of the IS element, ISEcp1, was present in the upstream region. This IS element has been found to be associated with several antibiotic resistance genes and is implicated in the transmission of these genes. [32] [33] [34] The transcriptional start site of bla CMY-7 was located in the ISEcp1, 183 nucleotides upstream from the initiation codon and the putative -10 and -35 promoter elements were located within the IS element. Cao et al. 32 reported the presence of ISEcp1 upstream of the extended spectrum β-lactamase, bla CTX-M -17 which also provided the promoter sequences for its expression. Sequences further upstream from bla CMY-7 showed similarity to the plasmid transfer gene, traA, of IncI1 plasmid R64. 25 The plasmid encoding bla CMY-7 was present in two copies in S. typhimurium strain at Pennsylvania State University on February 21, 2013 http://jac.oxfordjournals.org/ Downloaded from 100 suggesting that plasmid copy number played a minimal role in overall expression of bla .
High-level ampC expression in the clinical isolate S. typhimurium strain 100 did not correlate with a decrease in invasion potential or growth rate compared to LT2 or LT2:pCMY-7. The invasion potential (8.3%) observed for the S. typhimurium strain 100 was comparable to those reported for other Salmonella isolates (12.3%; 16 14.5% 35 ). However, invasion potential can vary with the strain of Salmonella and type of mammalian cells used. 16, 35 The ∼3-fold increase in invasion potential of LT2:pCMY-7 in comparison to LT2 was an interesting observation. Invasion of mammalian cells by Salmonella is a complex process that involves coordinated function of a number of gene products. Most of the invasion genes are clustered together in a region of the chromosome described as Salmonella pathogenicity island 1. It has been observed that certain genes present on a high molecular weight plasmid can also play an important role. 36, 37 The increase in invasion potential of the transconjugant LT2:pCMY-7 in comparison to LT2 suggests that the large plasmid which was transferred may encode invasion associated gene(s) in addition to bla . A lower growth rate and invasion potential was observed for the transformant, LT2:pAH1. These data support the observation by Morosini et al. 16 that high-level ampC expression can affect the invasion and growth rate for Salmonella. However, taken together, these data indicate that high-level production of AmpC β-lactamases in clinical isolates of Salmonella can be compensated in the organisms by mechanisms other than the repression of ampC expression.
Salmonella enteritis is a self-limiting disease and antibiotics are usually not prescribed to treat the infection. 38 However, the incidence of multidrug-resistant S. typhimurium is on the rise 39, 40 and Salmonella infections may be a cause for concern especially in children and individuals with compromised immune function. 38, 41 Therefore, when a virulent pathogen such as Salmonella becomes multidrug-resistant, it poses a greater therapeutic challenge. The ability of S. typhimurium to maintain virulence in the presence of high-level ampC expression demonstrates the versatility of this virulent pathogen and the need for vigilant surveillance of these types of resistance mechanisms in Salmonella spp.
